FDA Inspection
Recipharm Uppsala ABRecipharm Uppsala AB – FDA Inspection, Mar 14, 2014
Record Details
This FDA Inspection record concerns Recipharm Uppsala AB, with an inspection on March 14, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Recipharm Uppsala AB
- Inspection Date
- March 14, 2014
- Product Type
- Drugs
View Company Profile
ID · ffd92d1c-9662-4635-94ff-0d3dfafc5d64
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 869566
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.101(d)Component addition checked by 2nd person
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Recipharm Uppsala AB
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2024 | VAI | Drug Quality Assurance | |
| August 26, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Recipharm Uppsala AB
- FDA Inspection 1301930 - 2024-04-17
- FDA Inspection 1210857 - 2021-08-26
- FDA Inspection 1028387 - 2017-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.